SONIRE Therapeutics is a clinical-stage medical device company.
SONIRE Therapeutics has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
SONIRE Therapeutics's investors include SBI Investment, Sante Ventures, Fast Track Initiative, Inc., Nomura SPARX.
SONIRE Therapeutics is headquartered in Palo Alto, United States.
SONIRE Therapeutics is a clinical-stage medical device company.
SONIRE Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SONIRE Therapeutics — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/sonire-therapeutics-palo-alto. Accessed October 21, 2026.
VCBacked. (2026). SONIRE Therapeutics — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/sonire-therapeutics-palo-alto
{{cite web |title=SONIRE Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sonire-therapeutics-palo-alto |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated